- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07629479
Ejaculation-Preserving Versus Standard Bipolar TUEP for BPH (EP-BTUEP)
Bipolar Transurethral Enucleation of the Prostate With Preservation of Ejaculation in Patients With Benign Prostatic Hyperplasia: A Randomized Controlled Trial
Visão geral do estudo
Status
Condições
Descrição detalhada
Benign prostatic hyperplasia is a common cause of lower urinary tract symptoms in aging men. Surgical treatment is indicated when medical therapy fails or when symptoms remain bothersome. Bipolar transurethral enucleation of the prostate is an established endoscopic surgical technique for benign prostatic obstruction, but standard endoscopic prostate surgery may be associated with loss of antegrade ejaculation.
This study will evaluate whether an ejaculation-preserving modification of bipolar transurethral enucleation of the prostate can preserve ejaculatory function while maintaining effective relief of lower urinary tract symptoms. The ejaculation-preserving technique will preserve the paracollicular tissue, the area approximately 1 cm proximal to the verumontanum, and bladder neck fibers, while avoiding deep enucleation behind the verumontanum. The control group will undergo standard bipolar transurethral enucleation of the prostate.
Eligible sexually active men with benign prostatic hyperplasia and lower urinary tract symptoms after failed medical treatment will be randomized in a 1:1 ratio to ejaculation-preserving B-TUEP or standard B-TUEP. Sexual and urinary outcomes will be assessed using validated questionnaires and objective urinary parameters. Follow-up assessments will include ejaculatory function, erectile function, International Prostate Symptom Score, post-void residual urine, uroflowmetry, perioperative complications, and need for retreatment.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Hany F Badawy, MD
- Número de telefone: +201149525028
- E-mail: HANYFATHY86@GMAIL.COM
Locais de estudo
-
-
Beni Suweif Governorate
-
Banī Suwayf, Beni Suweif Governorate, Egito
- Recrutamento
- Department of Urology- Beni-Suef University Hospitals
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Male patients with lower urinary tract symptoms secondary to benign prostatic obstruction after failed medical treatment for at least 3 months.
- Sexually active patients with a continuous relationship with the same partner.
- International Prostate Symptom Score of 8 or greater.
- Transrectal ultrasound-estimated prostate size between 40 and 100 cc.
- Eligible for bipolar transurethral enucleation of the prostate.
- Ability to complete the required sexual and urinary function questionnaires.
- Ability to provide written informed consent.
Exclusion Criteria:
- Preoperative sexual dysfunction.
- Preoperative ejaculatory dysfunction.
- Diagnosis or suspicion of prostate cancer.
- Neurological disorders affecting lower urinary tract or sexual function.
- Detrusor hypocontractility.
- Catheter-dependent patients.
- Patients with bladder stones.
- Inability or refusal to provide informed consent.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Ejaculation-Preserving B-TUEP
Participants assigned to this arm will undergo ejaculation-preserving bipolar transurethral enucleation of the prostate.
The technique will preserve the paracollicular tissue, the area approximately 1 cm proximal to the verumontanum, and bladder neck fibers, while avoiding deep enucleation behind the verumontanum.
|
Ejaculation-preserving bipolar transurethral enucleation of the prostate will be performed with preservation of the paracollicular tissue, the area approximately 1 cm proximal to the verumontanum, and bladder neck fibers, while avoiding deep enucleation behind the verumontanum.
|
|
Comparador Ativo: Standard B-TUEP
Participants assigned to this arm will undergo standard bipolar transurethral enucleation of the prostate without the ejaculation-preserving modifications used in the experimental arm.
|
Standard bipolar transurethral enucleation of the prostate will be performed according to the conventional surgical technique without preservation of the paracollicular tissue and the area approximately 1 cm proximal to the verumontanum.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Male Sexual Health Questionnaire Ejaculatory Dysfunction Short Form Function Score From Baseline to 6 Months
Prazo: Baseline and 6 months postoperatively
|
Ejaculatory function will be assessed using the Male Sexual Health Questionnaire Ejaculatory Dysfunction Short Form function score.
The function score is based on three ejaculatory function items assessing ejaculation frequency, ejaculation force, and ejaculation volume.
The total function score ranges from 1 to 15, with higher scores indicating better ejaculatory function.
The outcome will be calculated as the 6-month postoperative score minus the baseline score.
A smaller decrease or a positive change indicates better preservation of ejaculatory function.
|
Baseline and 6 months postoperatively
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Male Sexual Health Questionnaire Ejaculatory Dysfunction Short Form Bother Score at 6 Months
Prazo: 6 months postoperatively
|
Ejaculatory bother will be assessed using the bother item of the Male Sexual Health Questionnaire Ejaculatory Dysfunction Short Form.
The bother score ranges from 0 to 5, with higher scores indicating greater bother related to ejaculatory dysfunction.
|
6 months postoperatively
|
|
Preservation of Antegrade Ejaculation at 6 Months
Prazo: 6 months postoperatively
|
The proportion of participants with preserved antegrade ejaculation at 6 months after surgery will be compared between the ejaculation-preserving B-TUEP group and the standard B-TUEP group.
Preserved antegrade ejaculation will be defined as patient-reported antegrade seminal emission during orgasm after resumption of sexual activity.
Participants reporting absent ejaculation, dry ejaculation, or retrograde ejaculation will be considered not to have preserved antegrade ejaculation.
|
6 months postoperatively
|
|
Change in International Index of Erectile Function-5 Score From Baseline to 6 Months
Prazo: Baseline and 6 months postoperatively
|
Erectile function will be assessed using the International Index of Erectile Function-5 questionnaire.
The total score ranges from 5 to 25, with higher scores indicating better erectile function.
The outcome will be calculated as the 6-month postoperative score minus the baseline score.
|
Baseline and 6 months postoperatively
|
|
Change in International Prostate Symptom Score From Baseline to 6 Months
Prazo: Baseline and 6 months postoperatively
|
Lower urinary tract symptoms will be assessed using the International Prostate Symptom Score.
The total score ranges from 0 to 35, with higher scores indicating more severe urinary symptoms.
The outcome will be calculated as the 6-month postoperative score minus the baseline score.
|
Baseline and 6 months postoperatively
|
|
Change in Maximum Urinary Flow Rate From Baseline to 6 Months
Prazo: Baseline and 6 months postoperatively
|
Maximum urinary flow rate will be measured by uroflowmetry and reported in milliliters per second.
The outcome will be calculated as the 6-month postoperative maximum urinary flow rate minus the baseline maximum urinary flow rate.
|
Baseline and 6 months postoperatively
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Hany F Badawy, MD, Faculty of medicine Beni-Suef University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- FMBSUREC07092025EjBTUEP
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .